(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 6.31% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 124.58%.
Rapid Micro Biosystems's revenue in 2025 is $30,289,000.On average, 1 Wall Street analysts forecast RPID's revenue for 2025 to be $1,423,572,562, with the lowest RPID revenue forecast at $1,423,572,562, and the highest RPID revenue forecast at $1,423,572,562.
In 2026, RPID is forecast to generate $1,733,044,858 in revenue, with the lowest revenue forecast at $1,733,044,858 and the highest revenue forecast at $1,733,044,858.